CN111773308A - Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method - Google Patents
Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method Download PDFInfo
- Publication number
- CN111773308A CN111773308A CN202010267049.9A CN202010267049A CN111773308A CN 111773308 A CN111773308 A CN 111773308A CN 202010267049 A CN202010267049 A CN 202010267049A CN 111773308 A CN111773308 A CN 111773308A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- preventing
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for preventing and treating novel coronavirus infection pneumonia and a preparation method thereof, wherein the Chinese medicinal composition comprises ephedra, gypsum, almond, platycodon root, cassia twig, white paeony root, honeysuckle flower, weeping forsythia, codonopsis pilosula and liquorice. Qualified traditional Chinese medicine formula granules are produced at home, and the tea substitute drink is prepared according to the proportion, is taken orally 1 or 2 times a day. It is used for 7-10 days. Under the guidance of the syndrome differentiation and treatment theory of traditional Chinese medicine, the clinical and theoretical principles are combined, and the advantages and characteristics of traditional Chinese medicine are highlighted. The traditional Chinese medicine composition for preventing and treating the novel coronavirus infection pneumonia and the preparation method thereof have theoretical basis, and have the functions of dispersing lung qi, consolidating superficial resistance, supporting vital qi, eliminating dampness, detoxifying, clearing away residual evil and enhancing immunity; it can be used for preventing and treating coronavirus pneumonia and other influenza viruses.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition of 'lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia and a preparation method thereof.
Background
Although to date, there are no specific western medicines for the new coronavirus. Therefore, the prevention and treatment of the novel coronavirus pneumonia by the traditional Chinese medicine are very important and urgent.
Pneumonia infected with a novel coronavirus is an acute infectious pneumonia, and the pathogen thereof is a novel coronavirus which has not been previously found in humans, namely, 2019novel coronavirus (2019novelcoronavirus, 2019-nCoV). The onset of the disease is fever, hypodynamia and dry cough, the dyspnea gradually appears, the infection source is still unclear at present, and the transmission paths are droplet transmission, contact transmission and fecal oral transmission. At 30/1/2020, the WHO announces a New Coronavirus Pneumonia (NCP) epidemic as an emergent public health event of international concern. There are numerous links and factors that affect infection by the novel coronavirus. The literature shows that the pathways of infection of 2019-nCoV and SARS-CoV2 viruses cause diseases by the virus invading the body through the combination of the expressed S-protein and angiotensin converting enzyme (ACE2) in the human body.
The influence of the novel coronavirus pneumonia mainly means that the lung governing qi function is influenced, the respiratory system of the novel coronavirus pneumonia is influenced, and the lung governs qi and respiration and is actually affiliated to the lung system. The basic conditions of even generation of lung respiration and smooth regulation of qi machines, the novel coronavirus pneumonia causes respiratory dysfunction and influences the generation and qi movement of pectoral qi, so that the qi governing the lung and the main respiration of the lung are obviously weakened, the respiratory function of the lung is seriously lost, clear qi cannot rise, turbid qi cannot emerge, gasification stops, and the life activities of people end.
In summary, the problems of the prior art are as follows:
at present, the pathophysiological mechanism of the novel coronavirus is not completely clarified, and no special medicine is available for modern medical treatment. First, it should be known what is currently urgent is the infection of pneumonia by a novel coronavirus (2019-? These problems can be considered and solved as quickly as possible. Preliminary analysis by professor li yue of my hospital: 1. another variation of the SARS virus may be from virology considerations, based on: the novel virus and SARS virus belong to coronavirus, which has genetic relationship with influenza virus, and although the vaccine against SARS virus is developed, the vaccine resistance is possible? Can bacteria resist drug antibiotics? Viruses are also possible. Western medicine mainly aims at viruses, treatment is very clear, but the fewer action targets are, the traditional Chinese medicine compound is multi-target, and the multi-target changes the internal environment, so that the medicine resistance environment is reduced for the viruses or the medicine resistance cannot be realized. A multi-target Chinese medicinal formula, namely lung ventilating and toxin expelling decoction, is drawn up, and the problem of drug resistance is solved from the aspects of a human body system and nature. 2. The principle of preventing and treating the novel coronavirus pneumonia in the traditional Chinese medicine follows the basic principle of the self rule of the traditional Chinese medicine, and the modernization of the traditional Chinese medicine is taken as a prevention and treatment measure, but the westernization is avoided.
We see the latest report of authoritative experts: the clinical features of Acute Respiratory Disease (ARD) caused by new coronaviruses are still unclear. In addition to the problems we have discussed above, studies have found that:
(1) the median latent period of the new coronary pneumonia is 3.0 days, and the maximum period can reach 24 days.
(2) Fever (87.9%) and cough (67.7%) are the most common symptoms, but fewer than half of the patients with fever (43.8%) are present at the clinic. Diarrhea (3.7%) and vomiting (5.0%) were rare.
(3) Patients with new coronary pneumonia receiving oxygen therapy, mechanical ventilation, intravenous antibiotics and oseltamivir therapy accounted for 38.0%, 6.1%, 57.5% and 35.8%, respectively.
The problem is solved:
preventive agents: based on the 'lung ventilating and toxin expelling decoction', the formula is strict, the human body function is improved, and the Chinese medicinal composition can be used as a preventive medicament. The problems of prevention before illness and prevention after illness are solved: the aim of preventing and treating the latent period is fulfilled (according to the research of Zhanshan academicians on fever (87.9 percent), fever is the struggle expression of vital qi and pathogenic factors, in the stage, if the body can be assisted, the functions of regulating the ying and guarding of the lung main qi can be increased, the effect of expelling the novel coronavirus can be achieved, and the disease prevention and the precaution are achieved)
The problems of improving the oxygen content of the lung and enhancing the autonomous ventilation are as follows: by improving the 'lung governing qi' and regulating 'ying-wei' function, the oxygen content and the autonomous ventilation of the lung can be enhanced. Reduce passive oxygen therapy and mechanical ventilation, and make self lung function passive form active, and reduce the use of the mechanical therapy
The method has the advantages that a new system problem of a traditional Chinese medicine early prevention and treatment theory of the new coronary pneumonia is established: the theory of 'lung governing qi' regulating 'ying and wei' is proposed to form 'theory-practice-clinic-foundation-summary': establishes and perfects a novel early combined medical system for preventing and treating the novel coronavirus pneumonia.
Inheriting an old prescription, creating a new prescription: based on the ancient disease names and the ancient prescription names of the traditional Chinese medicine, such as typhoid fever, epidemic febrile diseases and the like, the current situation of treating the novel coronavirus pneumonia is researched and treated by combining the latest traditional Chinese and western medicines in China, and the traditional Chinese medicine scheme in the fourth version of the scheme definitely divides the clinical treatment into 4 stages, namely the early stage of cold-dampness stagnation in the lung. Based on the theory of 'regulating lung qi and regulating ying and wei', the traditional Chinese medicine formula 'lung-ventilating and toxin-expelling decoction'.
Solving the problem of drug resistance: the traditional Chinese medicine formula 'lung-ventilating and toxin-expelling decoction' changes the internal environment by multiple targets, so that the natural environment of the decoction is reduced or the decoction cannot resist medicine.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a traditional Chinese medicine composition of 'lung ventilating and toxin expelling decoction' for preventing novel coronavirus infection pneumonia and a preparation method thereof.
The invention is realized in such a way that a Chinese medicinal composition of 'lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia comprises the following components: ephedra, gypsum, almond, platycodon grandiflorum, cassia twig, white paeony root, honeysuckle, weeping forsythia, codonopsis pilosula and liquorice.
The preferred technical scheme is as follows:
the traditional Chinese medicine granule is prepared from qualified traditional Chinese medicine formula granules produced by enterprises, and comprises the following components in parts by weight: 3-10 parts of ephedra, 5-20 parts of gypsum, 4-15 parts of almond, 5-15 parts of platycodon grandiflorum, 4-12 parts of cassia twig, 3-15 parts of white paeony root, 3-15 parts of honeysuckle, 2-15 parts of fructus forsythiae, 4-15 parts of codonopsis pilosula and 2-10 parts of liquorice.
The most preferable prevention technical scheme is as follows: the composition comprises the following components in parts by weight: 3 parts of ephedra, 6 parts of gypsum, 5 parts of apricot kernel, 5 parts of platycodon grandiflorum, 4 parts of cassia twig, 4 parts of white paeony root, 4 parts of honeysuckle, 3 parts of fructus forsythiae, 5 parts of codonopsis pilosula and 3 parts of liquorice.
The most preferred treatment regimen is: the composition comprises the following components in parts by weight: 9 parts of ephedra, 20 parts of gypsum, 15 parts of apricot kernel, 15 parts of platycodon grandiflorum, 10 parts of cassia twig, 10 parts of white paeony root, 15 parts of honeysuckle, 15 parts of weeping forsythia, 15 parts of radix codonopsitis and 10 parts of liquorice.
The preparation method can adopt qualified Chinese medicinal formula granules produced at home to prepare tea substitute drink according to the proportion. It is administered orally 1 or 2 times daily instead of tea. The prevention is carried out for 7-10 days, and the treatment days are adjusted according to the disease condition.
The traditional Chinese medicine composition for treating and preventing the novel coronavirus infection pneumonia, namely the lung ventilating and toxin expelling decoction, further comprises:
the No. 1 traditional Chinese medicine formula particle, wherein the No. 1 traditional Chinese medicine is rhodiola rosea;
or the No. 2 traditional Chinese medicine formula particle, wherein the No. 2 traditional Chinese medicine is astragalus and dwarf lilyturf tuber;
or 3 # Chinese medicinal granule, wherein the 3 # Chinese medicinal materials are radix Aconiti lateralis Preparata and fructus Lycii.
The preferred scheme is as follows:
a patient with yin deficiency and dryness heat type is added with a No. 1 traditional Chinese medicine formula granule, wherein the No. 1 traditional Chinese medicine is prepared from 5-10 parts of rhodiola rosea and 6 g;
a traditional Chinese medicine formula particle No. 2 or a traditional Chinese medicine formula particle for patients with deficiency of both qi and yin is added, wherein the traditional Chinese medicine No. 2 is prepared from 9-30 parts of astragalus membranaceus and 4-15 parts of radix ophiopogonis by weight;
a traditional Chinese medicine formula particle No. 3 or used for patients with yin-yang deficiency is added, wherein the traditional Chinese medicine No. 3 comprises 5-10 parts of cooked monkshood 6g and 5-10 parts of medlar 6 g.
The most preferred preventive regimen is:
a patient with yin deficiency and dryness heat type is added with a No. 1 traditional Chinese medicine formula granule, wherein the No. 1 traditional Chinese medicine is 6 parts of rhodiola rosea;
a2 # traditional Chinese medicine formula particle is added for a patient with deficiency of both qi and yin, wherein the 2 # traditional Chinese medicine is 10 parts of astragalus and 5 parts of ophiopogon root;
a3 # traditional Chinese medicine formula particle is added for a patient with yin-yang deficiency, wherein the 3 # traditional Chinese medicine comprises 6 parts of cooked monkshood and 6 parts of medlar.
The most preferred treatment regimen is:
a patient with yin deficiency and dryness heat type is added with a No. 1 traditional Chinese medicine formula granule, wherein the No. 1 traditional Chinese medicine is 10 parts of rhodiola rosea;
a2 # traditional Chinese medicine formula particle is added for a patient with deficiency of both qi and yin, wherein the 2 # traditional Chinese medicine is 20 parts of astragalus and 10 parts of ophiopogon root;
a3 # traditional Chinese medicine formula particle is added for a patient with yin-yang deficiency, wherein the 3 # traditional Chinese medicine comprises 10 parts of cooked monkshood and 10 parts of medlar.
The 1-3 Chinese medicines are added with the formula of the lung ventilating and toxin expelling decoction according to the proportion every time, and are drunk as tea for oral administration 1 or 2 times a day. It is used for 7-10 days. The treatment days are adjusted according to the disease condition.
The traditional Chinese medicine composition for treating and preventing the novel coronavirus infection pneumonia, namely the lung ventilating and toxin expelling decoction, can be prepared into various medically acceptable dosage forms by using medically common auxiliary materials.
The preparation method of the traditional Chinese medicine composition of lung ventilating and toxin expelling decoction comprises the following steps:
selecting a Chinese medicinal composition 'lung ventilating and toxin expelling decoction' for preventing the novel coronavirus infection pneumonia,
mixing uniformly according to the proportion;
making a tea substitute drink;
determining the amount of the tea substitute.
Preferably, qualified Chinese medicinal formula granules are produced at home, and the tea substitute drink is prepared according to the proportion, is taken orally 1 time or 2 times per day for 7-10 days for prevention.
The invention also provides application of the traditional Chinese medicine composition for preventing and treating the novel coronavirus infection pneumonia, namely the lung ventilating and detoxifying decoction, in preventing and treating the novel coronavirus infection pneumonia.
Furthermore, the preparation method, the process and the method for preventing and treating the novel coronavirus infection pneumonia 'lung ventilating and toxin expelling decoction' traditional Chinese medicine formula can be selected on the basis of no loss of the curative effect of the formula.
In summary, the advantages and positive effects of the invention are:
the advantages and features of traditional Chinese medicine are highlighted by combining the clinical and theoretical principles under the guidance of the syndrome differentiation and treatment system theory of traditional Chinese medicine.
The invention has theoretical basis when the traditional Chinese medicine formula of 'lung ventilating and toxin expelling decoction' for preventing the novel coronavirus infection pneumonia, and has the effects of clinically improving the immunity, the lung function and the like; the same formula is not available at home and abroad.
In 2020, according to the invention, the city science and technology administration organizes the city prevention and control expert group to perform demonstration and screening according to the Schchen desk council and the city government 'urgent notice on developing the special science and technology attack for emergency pneumonia epidemic situation prevention and control of novel coronavirus infection'. The subject is used for the early research of preventing and treating the novel coronavirus pulmonary inflammation based on the theory of regulating the lung governing qi and regulating the ying and wei, and is listed as an emergency special scientific and technological link.
Composition and interpretation
The formula idea is as follows: 1 in accordance with the principle of diagnosis and treatment of pneumonia infected by the national novel coronavirus (trial fourth edition), cold-damp stagnation of lung in the early stage. The treatment is to ventilate the lung, eliminate dampness and regulate ying and wei (ying and wei are not harmonized to form cold-dampness entering the interior). 2. Aims at pathogenesis and physiological function of lung (visceral manifestation of lung), and the lung's functions of governing qi ', dispersing and descending '. 3. Accords with the principle of 'monarch, minister, assistant and guide' of the traditional Chinese medicine formula, strives for scientific and rigorous compatibility, and highlights the characteristics of the traditional Chinese medicine.
The prescription is as follows:
based on the theory of 'regulating lung qi and regulating ying and wei', professor of Li Ruiyu in our hospital draws up a traditional Chinese medicine formula 'Xuanfei Jiedu Tang'. The medicine composition is as follows: ephedra, gypsum, almond, platycodon grandiflorum, cassia twig, white paeony root, honeysuckle, weeping forsythia, codonopsis pilosula and liquorice.
And (3) reading the formula:
ephedra and gypsum: the ephedra herb is pungent and warm, and can promote the dispersing of lung qi and induce diuresis (another way for pathogenic qi to be discharged from the bladder through dispersing lung qi); gypsum, Gypsum Fibrosum, being pungent and cold, clears lung heat; the combination of the first and second herbs has the actions of dispersing lung qi and clearing heat.
Almond and platycodon grandiflorum: the bitter apricot kernel, bitter and neutral in flavor, enters lung, spleen and large intestine channels (another way for pathogenic qi to pass through the lung and be discharged from the large intestine), and has the functions of relieving cough and asthma, and relaxing bowel. The pungent platycodon root, radix Platycodi enters lung meridian, and has the effects of dispersing lung qi, dispelling cold, eliminating phlegm and expelling pus. The platycodon root ascends to promote lung qi, the almond bitter and flat to descend the lung qi, ascend and descend, regulate the lung qi and strengthen the lung descending function.
Cassia twig and white peony root: ramulus Cinnamomi has effects of tonifying yang, relieving exterior syndrome, warming channels, dredging collaterals, and invigorating middle-warmer energy; bai Shao is sour and astringent in nature, so it can astringe yin and consolidate nutrient and stop sweating. Gui Zhi is combined with Bai Shao to be the right herb. Ramulus Cinnamomi is distributed and collected externally, and radix Paeoniae is collected internally to help defend and resist pathogens during distribution and to consolidate yin during collection. The cassia twig and the white peony root are closely matched with one another to disperse and collect, and coordinate ying and wei.
Honeysuckle and forsythia: honeysuckle flower and weeping forsythia are pungent, cool, mild in nature, capable of ventilating the lung and expelling pathogenic factors, aromatic in flavor, capable of dispelling turbidity, and capable of clearing away heat and toxic materials; honeysuckle flower forsythia is a medicine for qi system (mainly clearing qi system heat, with reinforcing 'ying wei' medicine in front, this time reinforcing 'qi system', forming 'lung-ying wei-qi system', with lung as main three lines of defense)
Dangshen and liquorice: the radix codonopsitis can tonify the middle-jiao and qi, and supplement the energy consumed by the medicines in ventilating the lung, ascending, descending, exiting and scattered collecting. Licorice root, radix Glycyrrhizae is effective in invigorating qi, regulating the middle warmer, and harmonizing the effects of the other drugs in the recipe.
The lung ventilating and toxin expelling decoction is prepared from ten medicines, but has the lung system, the ying and wei system, the qi system and the system medicine synergistic functions of ascending, descending, exiting, scattering and collecting, exterior and interior, ying and wei and the like. The thought is from ephedra decoction, ephedra, gypsum and licorice decoction, cassia twig decoction, honeysuckle flower and forsythia powder, platycodon root decoction, liquorice decoction and the like. It is a big "project", but stands out "big way to simple".
Simple form of pathogenesis, symptom, therapeutic method and prescription
Pathogenesis: cold-dampness stagnating the lung and disturbing the ying-defensive system (exogenous pathogenic factors attacking the lung, failure of lung qi to disperse, disharmony between ying-defensive system)
The disease symptoms are as follows: fever, aversion to cold, aversion to wind, scanty sweat, tinnitus and retching
Therapeutic method: opening and ventilating lung qi and harmonizing yingfen and weifen
The prescription is as follows: lung-ventilating and toxin-expelling soup
Drawings
Fig. 1 is a flow chart of a preparation method of a traditional Chinese medicine formula composition 'lung-ventilating and toxin-expelling decoction' for preventing and treating novel coronavirus infection pneumonia provided by the embodiment of the invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
The following detailed description of the principles of the invention is provided in connection with the accompanying drawings.
The invention provides a Chinese medicinal composition 'lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia, which comprises the following components in part by weight: 3g of ephedra, 6g of gypsum, 5g of almond, 5g of platycodon grandiflorum, 4g of cassia twig, 4g of white peony root, 4g of honeysuckle, 3g of fructus forsythiae, 5g of codonopsis pilosula and 3g of liquorice.
As shown in fig. 1, the preparation method of the traditional Chinese medicine composition 'lung-ventilating and toxin-expelling decoction' for preventing and treating the novel coronavirus infection pneumonia provided by the embodiment of the invention comprises the following steps:
s101, selecting the traditional Chinese medicine formula particles.
And S102, uniformly mixing the components in proportion.
S103, determining the drinking amount of the substitute tea.
S104, preparing the tea substitute drink.
S105, preparing the traditional Chinese medicine formula granules according to the proportion into a tea substitute drink package, selecting a No. 1-3 traditional Chinese medicine dosage formula according to syndrome differentiation treatment, adding the lung ventilating and toxin expelling decoction formula for each time, and drinking the tea substitute drink for 1 or 2 times a day for oral administration. It is used for 7-10 days.
The preparation method of the traditional Chinese medicine composition 'lung-ventilating and toxin-expelling decoction' for preventing and treating the novel coronavirus infection pneumonia provided by the embodiment of the invention comprises the following steps:
3g of ephedra, 6g of gypsum, 5g of almond, 5g of platycodon grandiflorum, 4g of cassia twig, 4g of white paeony root, 4g of honeysuckle, 3g of fructus forsythiae, 5g of codonopsis pilosula and 3g of liquorice. The above Chinese medicinal granule can be decocted with water to obtain decoction according to conventional Chinese medicinal preparation method. (prevention dose)
Furthermore, when a patient takes the traditional Chinese medicine formula of 'lung ventilating and toxin expelling decoction' for preventing and treating the novel coronavirus infection pneumonia, the No. 1-3 traditional Chinese medicines can be selected according to the dialectical condition of the traditional Chinese medicine. (the procedure is the same as in the above two methods).
Wherein, the No. 1 traditional Chinese medicine is added for patients with yin deficiency and dryness-heat. The No. 1 traditional Chinese medicine is prepared from 6g of rhodiola rosea;
wherein, the Chinese medicinal composition No. 2 is added for patients with deficiency of both qi and yin. The No. 2 traditional Chinese medicine is prepared from 10g of astragalus and 5g of dwarf lilyturf tuber;
wherein, the Chinese medicine No. 3 is added for the patient with yin-yang deficiency. The No. 3 traditional Chinese medicine is prepared from 6g of cooked monkshood and 6g of medlar;
the preparation is prepared by selecting dosage of No. 1-3 Chinese medicinal granule according to syndrome differentiation or decocting with water according to conventional preparation method, and is administered orally 1 or 2 times per day instead of tea. It is used for 7-10 days.
The traditional Chinese medicine composition 'lung ventilating and toxin expelling decoction' for preventing and treating the novel coronavirus infection pneumonia provided by the embodiment of the invention comprises the following components in parts by weight: 9 parts of ephedra, 20 parts of gypsum, 15 parts of almond, 15 parts of platycodon grandiflorum, 10 parts of cassia twig, 10 parts of white paeony root, 15 parts of honeysuckle, 15 parts of weeping forsythia, 15 parts of codonopsis pilosula and 10 parts of liquorice.
As shown in fig. 1, the preparation method of the traditional Chinese medicine composition 'lung-ventilating and toxin-expelling decoction' for preventing and treating the novel coronavirus infection pneumonia provided by the embodiment of the invention comprises the following steps:
s101, selecting the traditional Chinese medicine formula particles.
And S102, uniformly mixing the components in proportion.
S103, determining the drinking amount of the substitute tea.
S104, preparing the tea substitute drink.
S105, preparing the traditional Chinese medicine formula granules according to the proportion into a tea substitute drink package, selecting a No. 1-3 traditional Chinese medicine dosage formula according to syndrome differentiation treatment, adding the lung ventilating and toxin expelling decoction formula for each time, and drinking the tea substitute drink for 1 or 2 times a day for oral administration. The treatment days are adjusted according to the disease condition.
The preparation method of the traditional Chinese medicine composition 'lung-ventilating and toxin-expelling decoction' for preventing and treating the novel coronavirus infection pneumonia provided by the embodiment of the invention comprises the following steps:
9g of ephedra, 20g of gypsum, 15g of almond, 15g of platycodon grandiflorum, 10g of cassia twig, 10g of white paeony root, 15g of honeysuckle, 15g of weeping forsythia, 15g of codonopsis pilosula and 10g of liquorice. The above Chinese medicinal granule can be prepared into decoction by decocting with water. (therapeutic amount)
Furthermore, when a patient takes the traditional Chinese medicine formula of 'lung ventilating and toxin expelling decoction' for preventing and treating the novel coronavirus infection pneumonia, the No. 1-3 traditional Chinese medicines can be selected according to the dialectical condition of the traditional Chinese medicine. (the procedure is the same as in the above two methods).
Wherein, the No. 1 traditional Chinese medicine is added for patients with yin deficiency and dryness-heat. The No. 1 traditional Chinese medicine is prepared from 10g of rhodiola rosea;
wherein, the Chinese medicinal composition No. 2 is added for patients with deficiency of both qi and yin. The No. 2 traditional Chinese medicine is prepared from 20g of astragalus and 10g of dwarf lilyturf tuber;
wherein, the Chinese medicine No. 3 is added for the patient with yin-yang deficiency. The No. 3 traditional Chinese medicine is prepared from 10g of cooked monkshood and 10g of medlar;
the preparation is prepared by selecting dosage of No. 1-3 Chinese medicinal granule according to syndrome differentiation or decocting with water according to conventional preparation method, and is administered orally 1 or 2 times per day instead of tea. The treatment days are adjusted according to the disease condition.
Furthermore, the preparation method, the process and the method for preventing the novel coronavirus infection pneumonia 'lung ventilating and toxin expelling decoction' traditional Chinese medicine formula can be selected on the basis of no loss of the curative effect of the formula.
The theoretical basis for the practice of the present invention is further described below.
The relationship between the theory of regulating ying and wei in "lung governing qi" and the prevention and treatment of novel coronavirus pneumonia
The understanding of the novel coronavirus (2019-:
in traditional Chinese medicine, the ancient disease names of "typhoid", "epidemic" and "epidemic" all include viral diseases. Viral diseases are more classified into the category of warm diseases in traditional Chinese medicine in the present generation, and are based on clinical manifestations of viral diseases, and have more similarities with warm diseases. The third edition of the national diagnosis and treatment of pneumonia infected by coronavirus (trial implementation) confirms that NCP belongs to the category of epidemic diseases in traditional Chinese medicine, causes the disease to be qi of epidemic crime, is located in the lung, and has the basic pathogenesis characteristics of dampness, heat, toxicity and stasis. The disease is also considered to belong to the category of epidemic diseases in traditional Chinese medicine, the core pathogenesis of the disease is damp toxin stasis, and the disease is located in lung and spleen and can injure collaterals and enter blood.
The theory of "lung governing qi regulating ying and wei" is as follows:
the lung, large intestine, skin and hair, nose, etc. constitute the lung system. The function of "lung governing qi" includes lung governing respiration and lung governing qi. Governing respiration in the lung means that the lung governs respiration, inhales natural clear qi, exhales turbid qi, and exchanges gas. Also included is "fur breathing". And a second air regulating machine. The general expression of qi activity refers to its basic form of movement, ascending, descending, exiting and entering. The lung also governs dispersing and descending physiological functions.
The nutrient and defensive qi are nutrient qi and defensive qi. Nutritive qi is the clear qi circulating in the vessels due to the micro-generation of food essence, and is rich in nutrition and called nutritive qi. The main physiological functions of nutritive qi include blood generation and whole body nutrition. Defensive qi is the vigorous qi generated by the differentiation of food essence and flowing out of the vessels, which has the meaning of "defending" and "protecting". The main functions are manifested in defense, warming and regulating the opening of muscle and skin striae. In contrast, nutrient qi pertains to nutrient yin and defensive qi pertains to defensive yang. Nutritive qi flows from the middle energizer (spleen and stomach) to the lung meridian of hand taiyin. The defensive qi comes from the lower energizer, and the first meridian is the bladder meridian of foot taiyang. The bladder meridian is in the lower energizer, and the kidney is exterior-interior to the bladder and belongs to the lower energizer. "Yin is in the interior and yang is on the right; yang in the exterior and yin in the interior "(Su Wen. Yin-Yang corresponding to the university of treatise fifth).
Improving the ' lung governing qi ' and regulating ying and wei ' functions is an important measure for preventing and treating novel coronavirus pneumonia:
briefly, the subject is to improve the "lung governing air" function through the lung system, to achieve "exclusion" -a novel coronavirus. The theoretical basis is that the healthy qi exists in the interior and the pathogenic factors cannot be dried; when pathogenic factors attack, qi must be deficient. The first defense line is established for the human body by the facts that the qi of the spring, summer, autumn and winter are different, the nutrition and the defense are compatible, the yin and the yang are harmonized, and the clear and turbid are not dry, and the disease is treated smoothly if the disease is treated smoothly.
Regulating ying-wei is regulating ying-qi and wei-qi, namely increasing nutrition, defending exogenous pathogens, namely regulating yin and yang (ying is yin and wei is yang), and improving the functions of acquired spleen and stomach (because ying-qi is in middle-jiao) and congenital kidney and bladder (because wei-qi is in middle-jiao). This can be said to set up a second line of defense for the human body
The first defense line and the second defense line have the functions which are improved together, and the positive significance is played on the combined innovation of the theory and practice of preventing and treating the novel coronavirus pneumonia.
The invention provides a Chinese medicinal composition 'Lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia, and the related clinical data comprise:
1) clinical data: selecting 12 patients in 12 cases of volunteer oral administration for preventing the novel coronavirus from infecting the pneumonia in the traditional Chinese and western medicine combined department of the second subsidiary hospital in the department of special sciences such as the higher medical science of the Schchen platform of the hospital from 1 month 10 in 2020 to 2 months 10 in 2020, wherein 7 men and 5 women are aged 24-58 years and averagely 35.1 years, and administering the lung ventilating and detoxifying soup to the patients for oral administration according to the pharmaceutical composition for 7-10 days. The patients with heart disease, pulmonary heart disease and the history of allergy of traditional Chinese medicines are excluded.
2) Observation indexes are as follows: detection of pulmonary function before and after oral administration, detection of immunological function (Ig-G, Ig-M, Ig-E)
3) The curative effect results are as follows: the 12 persons who voluntarily take the lung ventilating and toxin expelling decoction to prevent the novel coronavirus from infecting pneumonia have obviously improved lung function detection and immunological function detection (Ig-G, Ig-M and Ig-E) before and after oral administration, and the difference has statistical significance (P is less than 0.05). The lung ventilating and toxin expelling soup has the functions of improving the lung function and the immunologic function.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.
Claims (11)
1. A traditional Chinese medicine composition of 'lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia is characterized by comprising the following components: ephedra, gypsum, almond, platycodon grandiflorum, cassia twig, white paeony root, honeysuckle, weeping forsythia, codonopsis pilosula and liquorice.
2. The traditional Chinese medicine composition of 'lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia according to claim 1, which consists of qualified traditional Chinese medicine formula particles, and comprises the following components in parts by weight: 3-10 parts of ephedra, 5-20 parts of gypsum, 4-15 parts of almond, 5-15 parts of platycodon grandiflorum, 4-12 parts of cassia twig, 3-15 parts of white paeony root, 3-15 parts of honeysuckle, 2-15 parts of fructus forsythiae, 4-15 parts of codonopsis pilosula and 2-10 parts of liquorice.
3. The traditional Chinese medicine composition of 'lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia as claimed in claim 2, which comprises the following components in parts by weight: 3 parts of ephedra, 6 parts of gypsum, 5 parts of almond, 5 parts of platycodon grandiflorum, 4 parts of cassia twig, 4 parts of white paeony root, 4 parts of honeysuckle, 3 parts of fructus forsythiae, 5 parts of codonopsis pilosula and 3 parts of liquorice.
4. The traditional Chinese medicine composition of 'lung ventilating and toxin expelling decoction' for preventing and treating novel coronavirus infection pneumonia as claimed in claim 2, which comprises the following components in parts by weight: 9 parts of ephedra, 20 parts of gypsum, 15 parts of almond, 15 parts of platycodon grandiflorum, 10 parts of cassia twig, 10 parts of white paeony root, 15 parts of honeysuckle, 15 parts of weeping forsythia, 15 parts of codonopsis pilosula and 10 parts of liquorice.
5. The Chinese medicinal composition of 'lung ventilating and toxin expelling decoction' for preventing and treating the novel coronavirus infection pneumonia according to any one of claims 1 to 4, which is characterized by further comprising:
the No. 1 traditional Chinese medicine formula particle, wherein the No. 1 traditional Chinese medicine is rhodiola rosea;
or the No. 2 traditional Chinese medicine formula particle, wherein the No. 2 traditional Chinese medicine is astragalus and dwarf lilyturf tuber;
or 3 # Chinese medicinal granule, wherein the 3 # Chinese medicinal materials are radix Aconiti lateralis Preparata and fructus Lycii.
6. The Chinese medicinal composition of 'lung ventilating and toxin expelling decoction' for preventing and treating the novel coronavirus infection pneumonia according to any one of claims 1 to 4, which is characterized by further comprising:
the No. 1 traditional Chinese medicine formula particle, wherein the No. 1 traditional Chinese medicine is 6-10 parts of rhodiola rosea;
or the No. 2 traditional Chinese medicine formula particle, wherein the No. 2 traditional Chinese medicine is 9-30 parts of astragalus and 4-15 parts of dwarf lilyturf tuber;
or 3, the 3 traditional Chinese medicine is prepared from 5-15 parts of cooked monkshood and 5-15 parts of medlar. A
7. The Chinese medicinal composition of 'lung ventilating and toxin expelling decoction' for preventing and treating the novel coronavirus infection pneumonia according to any one of claims 1 to 4, which is characterized by further comprising:
a patient with yin deficiency and dryness heat type is added with a No. 1 traditional Chinese medicine formula granule, wherein the No. 1 traditional Chinese medicine is 6 parts of rhodiola rosea;
a2 # traditional Chinese medicine formula particle is added for a patient with deficiency of both qi and yin, wherein the 2 # traditional Chinese medicine is 10 parts of astragalus and 5 parts of ophiopogon root;
a3 # traditional Chinese medicine formula particle is added for a patient with yin-yang deficiency, wherein the 3 # traditional Chinese medicine comprises 6 parts of cooked monkshood and 6 parts of medlar.
Or:
a patient with yin deficiency and dryness heat type is added with a No. 1 traditional Chinese medicine formula granule, wherein the No. 1 traditional Chinese medicine is 10 parts of rhodiola rosea;
a2 # traditional Chinese medicine formula particle is added for a patient with deficiency of both qi and yin, wherein the 2 # traditional Chinese medicine is 20 parts of astragalus and 10 parts of ophiopogon root;
a3 # traditional Chinese medicine formula particle is added for a patient with yin-yang deficiency, wherein the 3 # traditional Chinese medicine comprises 10 parts of cooked monkshood and 10 parts of medlar.
8. The Chinese medicinal composition for preventing and treating the novel coronavirus infection pneumonia according to any one of claims 1 to 6, which is prepared into various pharmaceutically acceptable dosage forms by further comprising medical commonly used auxiliary materials.
9. The Chinese medicinal composition of 'lung ventilating and toxin expelling decoction' for preventing and treating the novel coronavirus infection pneumonia according to any one of claims 1 to 6, wherein the preparation method of the Chinese medicinal composition of 'lung ventilating and toxin expelling decoction' comprises the following steps:
selecting a Chinese medicinal composition 'lung ventilating and toxin expelling decoction' for preventing the novel coronavirus infection pneumonia,
mixing uniformly according to the proportion;
making a tea substitute drink;
determining the amount of the tea substitute.
10. The Chinese medicinal composition for preventing and treating the novel coronavirus infection pneumonia according to any one of claims 1-6, wherein qualified Chinese medicinal formula granules in China are adopted to prepare tea substitute drinks according to the proportion, the tea substitute drinks are taken orally 1 or 2 times a day, and the prevention time is 7-10 days; the treatment days are adjusted according to the disease condition.
11. Use of a Chinese medicinal composition comprising the decoction for preventing and treating novel coronavirus infection pneumonia of any one of the above claims in preventing and treating novel coronavirus infection pneumonia.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010267049.9A CN111773308A (en) | 2020-04-07 | 2020-04-07 | Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010267049.9A CN111773308A (en) | 2020-04-07 | 2020-04-07 | Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111773308A true CN111773308A (en) | 2020-10-16 |
Family
ID=72753124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010267049.9A Pending CN111773308A (en) | 2020-04-07 | 2020-04-07 | Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111773308A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112289378A (en) * | 2020-11-02 | 2021-01-29 | 博奥生物集团有限公司 | Method for determining Chinese medicinal composition and method for determining medicinal effect thereof |
| CN112687370A (en) * | 2020-12-28 | 2021-04-20 | 博奥生物集团有限公司 | Electronic prescription generation method and device and electronic equipment |
| CN113304218A (en) * | 2021-06-21 | 2021-08-27 | 吉林大学 | Traditional Chinese medicine for treating feline calicivirus infection |
| CN115486488A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition for common food and application thereof |
| CN116407597A (en) * | 2023-03-27 | 2023-07-11 | 首都医科大学附属北京中医医院 | Xuan Bai pulse-activating decoction for resisting coronavirus and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102100856A (en) * | 2009-12-17 | 2011-06-22 | 苏州知微堂生物科技有限公司 | Nano traditional Chinese medicine for treating bronchial asthma and preparation technology |
-
2020
- 2020-04-07 CN CN202010267049.9A patent/CN111773308A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102100856A (en) * | 2009-12-17 | 2011-06-22 | 苏州知微堂生物科技有限公司 | Nano traditional Chinese medicine for treating bronchial asthma and preparation technology |
Non-Patent Citations (2)
| Title |
|---|
| 侠客行: "麻杏石甘汤，专用药首次！官方公布中医治疗方案值得注意的是，此次试行第三版新冠肺炎", 《UBA.EASTMONEY.COM/NEWS,002019,900347048.HTML》 * |
| 吴铁军: ""清肺排毒汤"中的经方——麻杏石甘汤", 《HTTPS://WWW.SOHU.COM/A/376763705_100033543》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112289378A (en) * | 2020-11-02 | 2021-01-29 | 博奥生物集团有限公司 | Method for determining Chinese medicinal composition and method for determining medicinal effect thereof |
| CN112687370A (en) * | 2020-12-28 | 2021-04-20 | 博奥生物集团有限公司 | Electronic prescription generation method and device and electronic equipment |
| CN112687370B (en) * | 2020-12-28 | 2023-12-22 | 北京博奥晶方生物科技有限公司 | Electronic prescription generation method and device and electronic equipment |
| CN113304218A (en) * | 2021-06-21 | 2021-08-27 | 吉林大学 | Traditional Chinese medicine for treating feline calicivirus infection |
| CN113304218B (en) * | 2021-06-21 | 2022-05-27 | 吉林大学 | Traditional Chinese medicine for treating feline calicivirus infection |
| CN115486488A (en) * | 2022-06-16 | 2022-12-20 | 南方医科大学深圳医院 | Tea drink composition for common food and application thereof |
| CN116407597A (en) * | 2023-03-27 | 2023-07-11 | 首都医科大学附属北京中医医院 | Xuan Bai pulse-activating decoction for resisting coronavirus and preparation method thereof |
| CN116407597B (en) * | 2023-03-27 | 2024-02-06 | 首都医科大学附属北京中医医院 | Xuan Bai pulse-activating decoction for resisting coronavirus and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111773308A (en) | Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method | |
| CN103920106A (en) | Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma | |
| CN111388582B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof | |
| CN103977314A (en) | Medicinal composition for treating respiratory diseases as well as preparation method and application of medicinal composition | |
| CN111467459B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia at recovery stage, application and preparation method thereof | |
| CN111569010B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating neocoronary pneumonia | |
| CN116139237B (en) | A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application | |
| CN104623555A (en) | Traditional Chinese medicine preparation for treating acute asthmatic bronchitis and preparation method thereof | |
| CN102727765B (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
| CN101317946B (en) | Medicament for treating chronic bronchitis, pneumonectasis and preparation method thereof | |
| CN104857232A (en) | Traditional Chinese medicine combination for curing phthisis | |
| CN109793852A (en) | A kind of cough-relieving, resolving sputum and the Chinese medicine composition relievingd asthma | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN103417920A (en) | Traditional Chinese medicine formula for treating interstitial pneumonia | |
| CN100457177C (en) | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney | |
| CN106177561A (en) | One treats phthisical Chinese medicine composition | |
| CN106581612A (en) | Traditional Chinese medicine recipe for treating pulmonary heart disease | |
| CN104274702A (en) | Traditional Chinese medicine preparation for treating chronic cardiac-failure qi deficiency and blood stasis and syndrome of internal stagnation of fluid-dampness | |
| CN103041268B (en) | Medicament for treating post-traumatic pneumonia | |
| CN103041266B (en) | Medicine for treating pediatric postoperative pneumonia | |
| CN102940792A (en) | Traditional Chinese medicine composition for treating wind-warm syndrome | |
| CN103041127A (en) | Traditional Chinese medicine composition for treating cough | |
| CN116585382A (en) | Rehabilitation traditional Chinese medicine preparation beneficial to virus infection pneumonia | |
| CN110368458A (en) | A kind of drug and preparation method thereof for severe pneumonia | |
| CN103007076A (en) | Chinese medicinal composition for treating acute bronchitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |